pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous
Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
Tislelizumab
Phase 3 · small molecule · Esophageal Squamous Cell Carcinoma (ESCC)
Tislelizumab for Esophageal Squamous Cell Carcinoma (ESCC) is a Phase 3 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code BGB-A317-311
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BEONE MEDICINES AUS PTY LTD
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- completed
- Trials
- 1